ID: ALA3245767

Max Phase: Preclinical

Molecular Formula: C17H22ClNO4

Molecular Weight: 303.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.O=C(O)CCCNCC(O)COc1cccc2ccccc12

Standard InChI:  InChI=1S/C17H21NO4.ClH/c19-14(11-18-10-4-9-17(20)21)12-22-16-8-3-6-13-5-1-2-7-15(13)16;/h1-3,5-8,14,18-19H,4,9-12H2,(H,20,21);1H

Standard InChI Key:  JCTJLPDKUVTHMQ-UHFFFAOYSA-N

Associated Targets(non-human)

Heart 171 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 303.36Molecular Weight (Monoisotopic): 303.1471AlogP: 2.03#Rotatable Bonds: 9
Polar Surface Area: 78.79Molecular Species: ZWITTERIONHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.93CX Basic pKa: 9.81CX LogP: -0.66CX LogD: -0.66
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.62Np Likeness Score: -0.34

References

1. Rauls DO, Baker JK..  (1979)  Relationship of nonspecific antiarrhythmic and negative inotropic activity with physicochemical parameters of propranolol analogues.,  22  (1): [PMID:423187] [10.1021/jm00187a018]

Source